Literature DB >> 14569382

[Surgical therapy of erectile dysfunction. Current status].

F J Martínez Portillo1, K-P Jünemann, M Sohn.   

Abstract

In the light of the current domination of oral pharmacotherapy for the treatment of erectile dysfunction, the aim of this paper is to give a critical and up-to-date overview of the possibilities of surgical therapy. We evaluate possible therapy options such as penile vein surgery, arterial revascularisation surgery and penile prosthetics surgery. Today, vein surgery has faded into total insignificance due to the efficiency of oral and intracavernous therapeutics, and as a result of the pathomechanism of cavernoveinous insufficiency and the disappointing long-term results published in the literature. A similar fate has been met by penile revascularisation surgery, which today is performed only in a very limited number patients with strict selection criteria such as age and exclusion of diabetes mellitus. Thus, aside from pharmacotherapy, penile prosthetics is the only surgical therapy option maintaining its significance as a cure for erectile dysfunction. There are convincing long-term results with a high degree of patient and partner satisfaction, high patient acceptance and a good functional durability of the mostly three-part hydraulic implants.

Entities:  

Mesh:

Year:  2003        PMID: 14569382     DOI: 10.1007/s00120-003-0419-z

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  23 in total

Review 1.  Surgery of the penis: reconstruction and prostheses.

Authors:  B Kaftan; M Fisch; F Schreiter
Journal:  Curr Opin Urol       Date:  2001-05       Impact factor: 2.309

2.  Long-term experience with salvage of infected penile implants.

Authors:  J J Mulcahy
Journal:  J Urol       Date:  2000-02       Impact factor: 7.450

3.  Serial assessment of efficacy and satisfaction profiles following penile prosthesis surgery.

Authors:  John P Mulhall; Absaar Ahmed; Jeffrey Branch; Marilyn Parker
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

Review 4.  Vasculogenic impotence. Arterial and venous surgery.

Authors:  D S Rao; C F Donatucci
Journal:  Urol Clin North Am       Date:  2001-05       Impact factor: 2.241

5.  Management of erectile impotence. Use of implantable inflatable prosthesis.

Authors:  F B Scott; W E Bradley; G W Timm
Journal:  Urology       Date:  1973-07       Impact factor: 2.649

6.  Clinical guidelines panel on erectile dysfunction: summary report on the treatment of organic erectile dysfunction. The American Urological Association.

Authors:  D K Montague; J H Barada; A M Belker; L A Levine; P W Nadig; C G Roehrborn; I D Sharlip; A H Bennett
Journal:  J Urol       Date:  1996-12       Impact factor: 7.450

7.  Sildenafil citrate (Viagra) in the treatment of men with erectile dysfunction in southern Latin America: a double-blind, randomized, placebo-controlled, parallel-group, multicenter, flexible-dose escalation study.

Authors:  E Becher; A Tejada Noriega; R Gomez; R Decia
Journal:  Int J Impot Res       Date:  2002-08       Impact factor: 2.896

8.  Mechanisms of venous occlusion during canine penile erection: an anatomic demonstration.

Authors:  G R Fournier; K P Juenemann; T F Lue; E A Tanagho
Journal:  J Urol       Date:  1987-01       Impact factor: 7.450

9.  Surgical treatment of penile veno-occlusive dysfunction: is it justified?

Authors:  D Berardinucci; A Morales; J P Heaton; J Fenemore; S Bloom
Journal:  Urology       Date:  1996-01       Impact factor: 2.649

10.  Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin E1 and penile implant surgery for erectile dysfunction in urology practice.

Authors:  Atul Rajpurkar; Chirpriya B Dhabuwala
Journal:  J Urol       Date:  2003-07       Impact factor: 7.450

View more
  1 in total

Review 1.  An overview of the diagnosis and treatment of erectile dysfunction.

Authors:  Sivaprakasam Sivalingam; Hashim Hashim; Hartwig Schwaibold
Journal:  Drugs       Date:  2006       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.